Respiratory Care Devices Market worth $33.6 billion by 2030
The report "Respiratory Care Devices Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Homecare Settings) - Global Forecast to 2030", is projected to reach USD 33.6 billion in 2030 from USD 23.6 billion in 2025, at a CAGR of 7.3% between 2025 and 2030. A blend of demographic, medical, and environmental factors is responsible for propelling the growth of the respiratory care devices market. One example is the increase in care global conditions. Asthma, sleep apnea, and chronic obstructive pulmonary disease (COPD) are some of the respiratory ailments that are typically seen due to smoking, the aging population, and the constantly rising levels of air pollution. COVID-19 expenditure on ventilators, oxygen therapies, and monitoring equipment increased awareness related to support. There is also an increasing demand for homecare portable respiratory equipment, which can be used outside of hospitals and clinics, indicating an expansion of the market. Examples include cloud-connected devices, wireless monitoring systems, and smart inhalers.
Browse 587 market data Tables and 63 Figures spread through 466 Pages and in-depth TOC on "Respiratory Care Devices Market - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/respiratory-care-368.html
The therapeutic devices segment is expected to account for the largest share of the respiratory care devices market, by product type, during the forecast period.
Therapeutic devices are necessary for managing and treating the majority of acute and chronic respiratory diseases. They are required to provide patients with COPD, asthma, sleep apnea, and respiratory failure with life-sustaining respiratory therapy. The devices include high-flow nasal cannula systems, CPAP and BiPAP devices, nebulizers, ventilators, and oxygen concentrators. The therapeutic equipment market has increased manifold due to the need for long-term home-based respiratory therapy, the global burden of chronic disease, and the increase in hospitalization.
COPD is expected to account for the largest share, by disease indication, in the respiratory care devices market during the forecast period.
The respiratory care devices market is dominated by Chronic Obstructive Pulmonary Disease (COPD), which is increasingly becoming a global phenomenon, especially in the elderly population. This is due to higher demand for non-invasive ventilators, oxygen concentrators, nebulizers, and monitors. Since COPD is progressive and irreversible, it requires constant care and long-term respiratory therapy. The disease is also escalated by high-risk factors prevalent in developing and developed countries, including smoking, air pollution, and occupational exposures. Furthermore, since COPD is hospitalized and receives exacerbations, constant use of respiratory equipment at home and in the hospital is required.
In 2024, North America accounted for the largest share of the respiratory care devices market.
The respiratory care devices market is segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa. The prevalence of chronic respiratory illnesses such as asthma, COPD, and sleep apnea is partly due to the aging population, extensive histories of smoking, and rising obesity. The strong healthcare infrastructure of the region and growing awareness of the significance of respiratory health enable early detection and treatment of such conditions. The COVID-19 pandemic also drove demand for oxygen therapy equipment and ventilators and hence created long-term interest and investment in respiratory care products. Large medical device firms, improved reimbursement policies, and quick adoption of new technology such as remote monitoring and telephonic integration of respiratory equipment have also driven the market.
The key players in the global respiratory care devices market are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (US), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & Co. KGaA (Germany), GE Healthcare (US), Masimo (US), Getinge (Sweden), Nihon Kohden Corporation (Japan), Hillrom & Welch Allyn (Baxter) (US), Teleflex Incorporated (Japan), Air Liquide (France), ICU Medical, Inc (US), AdaptHealth, LLC (US), Hamilton Medical (Switzerland), Medline Industries, LP (US), Allied Medical, LLC (US), Nonin (US), Apex Medical (Taiwan), Rotech Healthcare Inc. (US), Löwenstein Medical SE & Co. KG (Germany), WEINMANN Emergency Medical Technology GmbH + Co. KG (Germany), Drive DeVilbiss Healthcare (US), OMRON Healthcare, Inc (Japan) and HUM GmbH (Germany).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Respiratory Care Devices Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
